Novartis Launching Lamisil AT With $20 Mil. TV/Print Ad Campaign

Novartis plans to spend $20 mil. on TV and print advertising in 1999 to launch Lamisil AT, the firm's new OTC athlete's foot medication. An Rx-to-OTC switch of the 1% terbinafine cream was approved by FDA March 9 ("The Tan Sheet" March 15, p. 11).